title: [New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam].
authors.affiliation: Institute of Rheumatology, RAMN.
authors.forename: E L
authors.initials: EL
authors.lastname: Nasonov
authors.forename: E S
authors.initials: ES
authors.lastname: Tsvetkova
authors.forename: R M
authors.initials: RM
authors.lastname: Balabanova
authors.forename: L N
authors.initials: LN
authors.lastname: Denisov
authors.forename: L I
authors.initials: LI
authors.lastname: Alekseeva
authors.forename: V A
authors.initials: VA
authors.lastname: Nasonova
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D000077239:Meloxicam; D011451:Prostaglandin-Endoperoxide Synthases / Q000187:drug effects / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000378:metabolism; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011453:Prostaglandins; D013843:Thiazines; D013844:Thiazoles; D011451:Prostaglandin-Endoperoxide Synthases; D000077239:Meloxicam